EBITDA of EBOS Group FY 2016-2023

Published by Statista Research Department, Jun 3, 2024

In financial year 2023, EBOS Group's Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) totaled 568.78 million Australian dollars. EBOS Group is an Australasian marketer, wholesaler and distributer of healthcare, medical, and pharmaceutical products and is publicly listed on the ASX.

EBITDA of EBOS Group in financial year 2016 to 2023 (in million Australian dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2023

Region

Australia, Australia and Oceania

Survey time period

financial year 2016 to 2023

Supplementary notes

EBITDA: Earnings Before Interest, Taxes, Depreciation and Amortization

Australia's financial year runs from July 1 to June 30; for example, financial year 2017 starts on July 1, 2016 and ends on June 30, 2017.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Australia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Australia

Overview

6

Prescription medication

5

Major Pharmaceuticals

5

Pharmaceutical retailers

7

Trends

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in AustraliaGlobal pharmaceutical industryDrug Store/Pharmacy Market in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.